Discussion regarding cash on hand, quality of public comms & management "performance" aside, the company is progressing on a number of fronts
TRIALS
https://classic.clinicaltrials.gov/ct2/results?cond=&term=incannex&cntry=&state=&city=&dist=
^ Most critical is that recruitment for Phase 2 IHL-42x has commenced (5 sites out of 25)
NEWS
https://capedge.com/company/1873875/IXHL
CLARION CLINICS
https://www.abc.net.au/listen/programs/lifematters/will-psychedelic-assisted-therapy-become-more-affordable-and-acc/103728780
For those wanting a bit more insight, reddit is your friend
https://www.reddit.com/r/INCANNEX_IXHL_NASDAQ/
For those in the red, for those not familiar with biotech investment and wondering if you should stick around, I suggest you read up on "sunk cost fallacy"
https://thedecisionlab.com/biases/the-sunk-cost-fallacy
DYOR, this is not financial advice yada yada
